Dr. Chinratanalab is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1310 24th Ave S
Nashville, TN 37212Phone+1 615-873-6373Fax+1 615-973-6374
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 2001
Texas Tech University Health Sciences Center at LubbockResidency, Internal Medicine, 1994 - 1997
Mahidol University Faculty of MedicineClass of 1990
Certifications & Licensure
TN State Medical License 2002 - 2026
AL State Medical License 1999 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 497 citationsHerceptin-induced Inhibition of Phosphatidylinositol-3 Kinase and Akt Is Required for Antibody-mediated Effects on p27, Cyclin D1, and Antitumor ActionF. Michael Yakes, Wichai Chinratanalab, Christoph A. Ritter, Walter King, Steven A. Seelig
Cancer Research. 2002-07-15 - 84 citationsIncidence and Outcome of Chronic Graft-versus-Host Disease Using National Institutes of Health Consensus CriteriaMadan Jagasia, Jennifer L. Giglia, Wichai Chinratanalab, S. Dixon, Heidi Chen
Biology of Blood and Marrow Transplantation. 2007-10-01 - 51 citationsClassic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).Madan Jagasia, Bipin N. Savani, George P. Stricklin, Brian G. Engelhardt, Adetola A. Kassim
Biology of Blood and Marrow Transplantation. 2009-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
